Cardiomyopathies
|
0.010 |
Biomarker
|
group |
BEFREE |
Instability of the mitochondrial alanyl-tRNA synthetase underlies fatal infantile-onset cardiomyopathy.
|
30285085 |
2019 |
Cardiac fibrosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Severe disruption of the editing activity of AlaRS caused embryonic lethality, whereas an intermediate reduction in AlaRS editing efficacy resulted in ubiquitinated protein aggregates and mitochondrial defects in cardiomyocytes that were accompanied by progressive cardiac fibrosis and dysfunction.
|
25422440 |
2014 |
Hereditary Diffuse Leukoencephalopathy with Spheroids
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
An AARS variant as the likely cause of Swedish type hereditary diffuse leukoencephalopathy with spheroids.
|
31775912 |
2019 |
Charcot-Marie-Tooth Disease, Axonal, Type 2n
|
0.710 |
CausalMutation
|
disease |
CLINVAR |
A major determinant for binding and aminoacylation of tRNA(Ala) in cytoplasmic Alanyl-tRNA synthetase is mutated in dominant axonal Charcot-Marie-Tooth disease.
|
20045102 |
2010 |
Charcot-Marie-Tooth Disease, Axonal, Type 2n
|
0.710 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Charcot-Marie-Tooth Disease, Axonal, Type 2n
|
0.710 |
CausalMutation
|
disease |
CLINVAR |
Exome Sequence Analysis Suggests that Genetic Burden Contributes to Phenotypic Variability and Complex Neuropathy.
|
26257172 |
2015 |
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29
|
0.700 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Charcot-Marie-Tooth Disease
|
0.160 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Hereditary Motor and Sensory-Neuropathy Type II
|
0.110 |
CausalMutation
|
disease |
CLINVAR |
A major determinant for binding and aminoacylation of tRNA(Ala) in cytoplasmic Alanyl-tRNA synthetase is mutated in dominant axonal Charcot-Marie-Tooth disease.
|
20045102 |
2010 |
Hereditary Motor and Sensory-Neuropathy Type II
|
0.110 |
CausalMutation
|
disease |
CLINVAR |
Hypermorphic and hypomorphic AARS alleles in patients with CMT2N expand clinical and molecular heterogeneities.
|
30124830 |
2018 |
Hereditary Motor and Sensory-Neuropathy Type II
|
0.110 |
CausalMutation
|
disease |
CLINVAR |
A recurrent loss-of-function alanyl-tRNA synthetase (AARS) mutation in patients with Charcot-Marie-Tooth disease type 2N (CMT2N).
|
22009580 |
2012 |
Charcot-Marie-Tooth Disease, Axonal, Type 2n
|
0.710 |
Biomarker
|
disease |
CTD_human |
|
|
|
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
Body mass index
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Epileptic encephalopathy
|
0.120 |
Biomarker
|
disease |
HPO |
|
|
|
Ataxia
|
0.110 |
Biomarker
|
phenotype |
HPO |
|
|
|
Microcephaly
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Muscle Spasticity
|
0.110 |
Biomarker
|
phenotype |
HPO |
|
|
|
Peripheral Nervous System Diseases
|
0.110 |
Biomarker
|
group |
HPO |
|
|
|
Autistic Disorder
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Blepharoptosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Blepharospasm
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Chorea
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Dwarfism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|